Action of CB1 and CB2 antagonists/inverse agonists on mantle cell lymphoma

Action of CB1 and CB2 antagonists/inverse agonists on mantle cell lymphoma

Show other versions (1)

In this study, the effects of antagonists to the cannabinoid receptors in MCL cell lines were studied. Results presented in this study show that signalling through cannabinoid receptor with antagonists such as SR141716, SR144528 decreases cell viability but hemopressin when analyzing with XTT. The d...

Full description

Bibliographic Details
Main Author:	Chui, Daniel
Format:	Others
Language:	English
Published:	Mälardalens högskola, Akademin för hållbar samhälls- och teknikutveckling 2011
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-12236

Similar Items

Action of CB1 and CB2 antagonists/inverse agonists on mantle cell lymphoma
by: Chui, Daniel
Published: (2011)

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018-06-01)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
by: Beatrice Polini, et al.
Published: (2020-12-01)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019-04-01)

A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats
by: Anushka V. Goonawardena, et al.
Published: (2011-01-01)

Midazolam-induced learning and memory impairment is modulated by cannabinoid CB1 receptor agonist and antagonist
by: Abdolaziz Ronaghi, et al.
Published: (2015-12-01)

Vascular dysfunction in a transgenic model of Alzheimer’s disease: Effects of CB1R and CB2R cannabinoid agonists.
by: Jorge Navarro-Dorado, et al.
Published: (2016-09-01)

Time-Dependent Protection of CB2 Receptor Agonist in Stroke.
by: Seong-Jin Yu, et al.
Published: (2015-01-01)

The Expression of the Generalized Drazin Inverse of A−CB
by: Xiaoji Liu, et al.
Published: (2012-01-01)

Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking.
by: Islam Gamaleddin, et al.
Published: (2012-01-01)

Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking
Published: ()

Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia
by: Changyu Pan, et al.
Published: (2011-01-01)

Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys
by: Joseph Bouskila, et al.
Published: (2016-01-01)

Synergistic Actions of Mu-Opioid and CB2 Receptor Agonists in Rodent Models of Acute and Chronic Pain
by: Grenald, Shaness A., et al.
Published: (2016)

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
by: Ken Soderstrom, et al.
Published: (2017-10-01)

The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas.
by: Eiron Cudaback, et al.
Published: (2010-01-01)

Dose-dependent effects of celecoxib on CB-1 agonist-induced antinociception in the mice
by: Mohammad Reza Zarrindast, et al.
Published: (2009-06-01)

Dose-dependent effects of celecoxib on CB-1 agonist-induced antinociception in the mice
by: Mohammad Reza Zarrindast, et al.
Published: (2009-04-01)

Cb-LIKE
by: Köhler, Martin
Published: (2015)

CB-SMoT+: UNA EXTENSIÓN AL ALGORITMO CB-SMoT
by: FRANCISCO MORENO, et al.
Published: (2012-12-01)

Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
by: Shuxian Jiang, et al.
Published: (2007-07-01)

Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells
Published: ()

CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)
by: Günter A. Müller, et al.
Published: (2020-02-01)

Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B
by: Erhei Dai, et al.
Published: (2017-06-01)

Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions
by: Eleftheria Lakiotaki, et al.
Published: (2015-01-01)

Protocol for crystal structure determination of the antagonist-bound human cannabinoid receptor CB2
by: Ling Shen, et al.
Published: (2021-06-01)

CB Asset Swap
by: Liu-chin Chimg, et al.
Published: (2002)

Ultrasonic studies of the liquid crystals (5CB), (8CB) and (9.CN)
by: Al-Kadir Kassim, A. A.
Published: (1981)

Vaccination trials in sheep against Chrysomya bezziana larvae using the recombinant peritrophin antigens Cb15, Cb42 and Cb48
by: Sukarsih, et al.
Published: (2000-10-01)

The CB1Cannabinoid Receptor in the Brain
by: Allyn C. Howlett
Published: (1998-12-01)

Le rôle des récepteurs aux cannabinoïdes CB1 et CB2 dans le guidage axonal
by: Argaw, Anteneh
Published: (2010)

Le rôle des récepteurs aux cannabinoïdes CB1 et CB2 dans le guidage axonal
by: Argaw, Anteneh
Published: (2010)

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5
by: Yaliang Tang, et al.
Published: (2021-04-01)

The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol
by: José Antonio López-Moreno, et al.
Published: (2007-02-01)

Agonists of CB1 and NMDA receptors decrease the toxic effect of organophosphorus compound paraoxon on PC12 cells
by: F. Salem, et al.
Published: (2019-10-01)

CB2 receptor agonist JWH133 activates AMPK to inhibit growth of C6 glioma cells
by: Wang Feng, et al.
Published: (2019-07-01)

The brain strikes back: Hypothalamic targets for peripheral CB1 receptor inverse agonism
by: Daniela Cota
Published: (2017-10-01)

Population-based input function modeling for [(18)F]FMPEP-d 2, an inverse agonist radioligand for cannabinoid CB1 receptors: validation in clinical studies.
by: Paolo Zanotti-Fregonara, et al.
Published: (2013-01-01)

Keys to the success of the CB Conquero
by: C. Fernández-Espínola, et al.
Published: (2016-12-01)

Keys to the success of the CB Conquero
by: C. Fernández-Espínola, et al.
Published: (2016-12-01)

Cannot write session to /tmp/vufind_sessions/sess_pk9ts1hgnvui6brt4jf4qnesca